Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesTransplantEmblemHealth investigational/HDE coverage & prior …
    Ask Trek AI about this page
    CurrentEmblemHealthPolicy N/A

    Medical Technologies Database — Investigational, Unproven, HDE, and Transplant Case Management Coverage Criteria

    Customize your policy alerts

    Sign up for all EmblemHealth policy alerts

    Know when EmblemHealth releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    This document lists medical technologies, devices, and procedures that EmblemHealth considers investigational, unproven, or subject to special handling (including HDE and FEHB notes) and describes program-level transplant case management; it affects providers submitting precertification/coverage requests for EmblemHealth members, including transplant program referrals.

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    Policy Summary
    PayerEmblemHealth
    PolicyMedical Technologies Database — Investigational, Unproven, HDE, and Transplant Case Management Coverage Criteria
    Policy CodePolicy N/A
    Change TypeNo material changes
    Effective DateN/A
    Last ReviewMar 13, 2026
    Next Review DateN/A
    Key ActionContact transplant case management at 1-800-447-0768 for review and coordination of transplant services and precertification.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    multipleitems listed as investigational/unproven or with special notes
    FEHBP/FEPFederal members special assessment rule
    1-800-447-0768Transplant case management phone
    HDE noteHDE/HUD guidance included

    Coverage Determinations and Investigational Listings

    Investigational / Unproven / Conditional Coverage Entries

    Entries in the Medical Technologies Database are assigned determinations (Y = covered, N = investigational/unproven, SEE NOTE) and special notes; examples below reflect listed stances and conditional handling.

    AbioCor HDE entry: AbioCor Implantable Replacement Heart is listed with HDE status and treated as investigational/SEE NOTE for commercial/Medicaid; precertification requests are reviewed on a case-by-case basis; Medicare coverage may follow the NCD for qualifying clinical study participants.
    Scalp cooling / cooling caps: Cooling caps and other scalp-cooling products are considered incidental to chemotherapy and are not separately reimbursed; products purchased by the member are generally considered excluded supplies (CPT 0662T, 0663T) with SEE NOTE distinctions by line of business.
    Deep brain stimulation (Reclaim DBS) / HDE devices: Reclaim™ DBS™ Therapy is described as investigational with HDE status; precertification requests for this device will be reviewed on a case-by-case basis.
    Gene expression profiling / molecular tests: Specific molecular and gene-expression tests (e.g., RUNX1, NPM1, CEBPA and related panels) are listed with Y determinations in defined contexts to guide therapeutic decision-making per the database entries.
    Other investigational procedures: Multiple procedures (e.g., laser interstitial thermotherapy [LITT] for many indications, microwave thermotherapy for chest wall recurrence, venoplasty for relapsing–remitting MS, select cryo/ablation and novel algorithmic imaging tools) are designated N (investigational/not medically necessary) in the Medical Technologies Database rows referenced.

    Cooling caps and other scalp cooling products used to prevent chemotherapy-induced alopecia are considered incidental to the administration of chemotherapy and are not separately reimbursed. Items purchased directly by the member (for example, Chemo Cold Cap, DigniCap, ElastoGel, Paxman Scalp Cooling System, Penguin Cold Cap) are treated as supplies and are generally excluded from coverage under plans that exclude supplies. Relevant CPT codes include 0662T and 0663T. (See plan-specific benefit language for any line-of-business exceptions where the entry is marked “SEE NOTE”.)

    The Medical Technologies Database lists multiple technologies and procedures as investigational or not medically necessary for specified indications. Examples include laser interstitial thermal therapy (LITT) for indications other than epilepsy and certain intracranial lesions (multiple CPTs such as 19499, 20999, 27599, 32999, 47399, 53899, 55899 designated N), microwave thermotherapy for chest wall recurrence of breast cancer (CPT 19499, N), nasal endoscopy with eustachian tube balloon dilation with mixed determinations depending on the entry, transpupillary thermotherapy for retinoblastoma where noted as Y in specific contexts, and venoplasty for relapsing–remitting multiple sclerosis (CPTs 36901–36906 designated N). The database also identifies other procedures (for example, vertebral stapling for idiopathic scoliosis, tremor analysis devices, and select telescreening algorithms) with investigational or conditional coverage stances; refer to each database row for the LOB-specific determination and effective date.

    Relevant CPT / HCPCS / Miscellaneous Codes

    AbioCor / HDE related CPT/HCPCSmixed
    33927listed in document for AbioCor
    33928listed in document for AbioCor
    33929listed in document for AbioCor
    L8698listed in document for AbioCor
    AbioCor / HDE related CPT/HCPCSmixed
    33927listed in document for AbioCor
    33928listed in document for AbioCor
    33929listed in document for AbioCor
    L8698listed in document for AbioCor
    Scalp cooling / Cooling caps CPTCPT
    0662Tscalp cooling (mentioned as incidental to chemotherapy)
    0663Tscalp cooling (mentioned as incidental to chemotherapy)
    Scalp cooling / Cooling caps CPTCPT
    0662Tscalp cooling (mentioned as incidental to chemotherapy)
    0663Tscalp cooling (mentioned as incidental to chemotherapy)
    Deep brain stimulation and related CPTsCPT
    21499listed for DBS (Reclaim) entries
    61863listed for DBS (Reclaim) entries
    61864listed for DBS (Reclaim) entries
    61867listed for DBS (Reclaim) entries
    61885listed for DBS/VNS entries
    61886listed for DBS/VNS entries
    61880listed for DBS (Reclaim) entries
    61888listed for DBS (Reclaim) entries
    Deep brain stimulation and related CPTsCPT
    21499listed for DBS (Reclaim) entries
    61863listed for DBS (Reclaim) entries
    61864listed for DBS (Reclaim) entries
    61867listed for DBS (Reclaim) entries
    61885listed for DBS/VNS entries
    61886listed for DBS/VNS entries
    61880listed for DBS (Reclaim) entries
    61888listed for DBS (Reclaim) entries
    Additional CPT / molecular / miscellaneous codes referencedmixed
    0046Ugene expression / molecular assay CPT listed
    0049Ugene expression / molecular assay CPT listed
    0050Ugene expression / molecular assay CPT listed
    81310NPM1 testing (listed)
    81218CEBPA testing (listed)
    81245listed
    81246listed
    19499miscellaneous CPT referenced for certain procedures
    36901venoplasty CPT referenced
    36902venoplasty CPT referenced
    1–10 of 14
    1/2
    Additional CPT / molecular / miscellaneous codes referencedmixed
    0046Ugene expression / molecular assay CPT listed
    0049Ugene expression / molecular assay CPT listed
    0050Ugene expression / molecular assay CPT listed
    81310NPM1 testing (listed)
    81218CEBPA testing (listed)
    81245listed
    81246listed
    19499miscellaneous CPT referenced for certain procedures
    36901venoplasty CPT referenced
    36902venoplasty CPT referenced
    1–10 of 14
    1/2

    Precertification, Review Requirements, and Provider Guidance

    Prior Authorization

    Prior Authorization Required for Investigational / HDE Devices

    Precertification / case-by-case review required for investigational or HDE devices listed (including AbioCor® Implantable Replacement Heart). Providers must submit a precertification request for review. Medicare members: costs directly related to services covered by the National Coverage Determination (NCD) will be paid by CMS intermediaries/carriers when beneficiaries are enrolled in a clinical study that meets the NCD criteria.

    • Affected codes: CPT 33927, 33928, 33929; HCPCS L8698
    • Commercial lines of business: case-by-case precertification review required
    • Medicare: see note — CMS payment applies per NCD for qualifying clinical study enrollment
    Note

    Transplant Case Management Contact

    Providers should refer transplant-eligible members to EmblemHealth’s transplant case management program for coordination of services and review. All requested transplant services are reviewed with the medical director supporting the transplant case management program and evaluated for medical necessity using evidence-based criteria.

    Key Definitions and Regulatory Notes

    Humanitarian Use Device (HUD) / Humanitarian Device Exemption (HDE) — definition and regulatory context
    HUD definitionA Humanitarian Use Device (HUD) is a medical device intended to benefit patients with a disease or condition that affects or is manifested in not more than 8,000 individuals in the United States per year (previously 4,000; increased to 8,000 on June 7, 2017).
    HDE definitionA Humanitarian Device Exemption (HDE) is a marketing application for an HUD that is exempt from the FD&C Act effectiveness requirements of Sections 514 and 515 and is subject to specific profit and use restrictions.
    Regulatory scopeHDEs allow marketing of devices for rare conditions without demonstrating effectiveness to the same standard as other devices, but remain subject to profit and use limitations.
    Annual prevalence thresholdThe HUD designation applies when the condition affects no more than 8,000 individuals in the U.S. per year.
    Historical noteThreshold increased from 4,000 to 8,000 individuals on June 7, 2017.

    Program Background and Medical Technologies Database

    EmblemHealth maintains a Medical Technologies Database that catalogs medical devices, procedures, and technologies and assigns each a coverage determination (for example, Y = covered, N = investigational/not medically necessary, or SEE NOTE for line-of-business exceptions). The database is used to standardize handling of items ranging from Humanitarian Device Exemption (HDE) products and scalp‑cooling devices to molecular testing and various procedural technologies. When services or devices listed as investigational or HDE are requested, precertification requests are reviewed on a case‑by‑case basis and may be escalated to the transplant program medical director or other clinical reviewers as applicable.

    Transplant Candidate and Program Review Criteria

    Transplant case management review

    Transplant program case management and review process applies to members preparing for or having transplants.

    Case review: All transplant services are reviewed with the assigned transplant program medical director; requested transplant services are reviewed for medical necessity using evidence-based criteria to support care coordination and outcomes.
    Program contact: To request transplant case management services or to coordinate review with the transplant program medical director, members and providers may call 1-800-447-0768.

    Medical Necessity Review and Evidence Requirements

    Documentation Required

    Evaluation requirements: medical necessity and evidence-based review

    Requested transplant services are reviewed for medical necessity using evidence-based criteria to support care coordination and outcomes; providers should engage transplant case management for coordination.

    • All requested transplant services undergo medical necessity review using evidence-based criteria.
    • Contact transplant case management for coordination of evaluations and care planning.

    Transplant Center and Program-Level Requirements

    Note

    Center requirements: medical director review and program oversight

    All transplant services are reviewed with the medical director assigned to support the transplant case management program; program-level oversight may be required for transplant-related precertification and case management.

    • Medical director involvement is required for review of transplant services.
    • Transplant program case management provides coordination and oversight for members preparing for or having transplants.

    Post-Transplant and Follow-up Review

    transplant services/case management — post-transplant and preparation services subject to program review and contact information
    Program scopeEmblemHealth's transplant program manages members with health care needs associated with preparing for or having a solid organ or bone marrow transplant.
    Medical director reviewAll transplant services are reviewed with the medical director assigned to support the transplant case management program.
    Medical necessity reviewAll requested transplant services are reviewed for medical necessity and evidence-based criteria are utilized to support care coordination and outcomes.
    How to request case managementTo request transplant case management services, members and providers may call 1-800-447-0768.
    Related guidanceFor additional information on experimental medical technologies, see the Medical Necessity Guidelines: Experimental.
    Policy Summary
    PayerEmblemHealth
    PolicyMedical Technologies Database — Investigational, Unproven, HDE, and Transplant Case Management Coverage Criteria
    Policy CodePolicy N/A
    Change TypeNo material changes
    Effective DateN/A
    Last ReviewMar 13, 2026
    Next Review DateN/A
    Key ActionContact transplant case management at 1-800-447-0768 for review and coordination of transplant services and precertification.
    SourceLink
    On This Page
    Coverage Determinations and Investigational ListingsRelevant CPT / HCPCS / Miscellaneous CodesPrecertification, Review Requirements, and Provider GuidanceKey Definitions and Regulatory NotesProgram Background and Medical Technologies DatabaseTransplant Candidate and Program Review CriteriaMedical Necessity Review and Evidence RequirementsTransplant Center and Program-Level RequirementsPost-Transplant and Follow-up Review
    • To request transplant case management services call 1-800-447-0768
    • All transplant services are reviewed with the transplant program medical director prior to authorization
    Documentation Required

    Provider Submission Requirements and Documentation

    When submitting requests for investigational technologies or devices, include complete documentation of clinical indications, prior therapies/trials (e.g., LVAD consideration), patient age, and rationale for device selection. Incomplete documentation may delay review or result in denial.

    • Include clinical notes, prior authorization history, and any relevant study enrollment information if applicable
    • For scalp cooling products: considered incidental to chemotherapy and not separately reimbursed; document accordingly
    Prior Authorization

    AbioCor® Precertification and Medicare Cost-Review Note

    AbioCor® Implantable Replacement Heart is FDA-approved under a Humanitarian Device Exemption (HDE) for a specific, limited patient population; precertification requests will be reviewed case-by-case for all lines of business except Medicare as noted. Ensure documentation confirms patient meets HDE criteria (e.g., <75 years old, severe biventricular end-stage heart disease, not transplant candidates, require multiple inotropic support, not eligible for LVAD destination therapy).

    • Confirm HDE eligibility criteria in the submission
    • Codes commonly associated: CPT 33927, 33928, 33929; HCPCS L8698
    • Medicare: costs related to services covered by the NCD may be paid by CMS when beneficiary is enrolled in qualifying clinical study